Poland – Medicinal products for the blood and blood-forming organs – ZAKUP DESMOPRESYNY DOŻYLNEJ WRAZ Z DOSTAWĄ DO REGIONALNYCH CENTRÓW KRWIODAWSTWA I KRWIOLECZNICTWA; znak postępowania: ZZP.ZP.411.95.2025
Opportunity Score
Confidence: 45%
Complexity: medium
24 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
Public tender for supply of intravenous desmopressin (4,200 ampoules) to regional blood centers in Poland, under the National Program for Hemophilia Treatment. Single lot, open procedure, award based on price (60%) and shelf life (40%). Estimated value not disclosed. Submission deadline: 2026-07-09 09:00 CET.
Strengths
Documents available
Open procedure
Medium complexity
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Valid marketing authorization (national or EU) for the medicinal product, category Rp or Rpz.
- Authorization must cover the entire contract duration.
- Proof of authorization as manufacturer/importer/exporter or wholesale distributor of medicinal products.
Buyer
Name
Narodowe Centrum Krwi
Location
Warszawa, POL
Website
Buyer profile
Identifier
5252378108
Lots (1)
Supply of intravenous desmopressin (Rp or Rpz category) for hemophilia A, von Willebrand disease, and platelet disorders. Total quantity: 4,200 ampoules. Delivery in three tranches: 1,400 amp. by 2026-07-24, 1,400 amp. by 2026-08-28, and 1,400 amp. by 2026-10-16. Product must include administration set. Purchaser may reduce quantity by up to 20%.
Procurement Details
Publication
08 Jun 2026
Deadline
09 Jul 2026, 09:00
Procedure
open
Contract
supplies
Language
POL
Publication #
394174-2026
Classification
Performance: Poland
Documents (2)
Opportunity Score
Confidence: 45%
Complexity: medium
24 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation